CARM1 is overexpressed in a variety of cancer types, and its high expression correlates with poor prognosis, particularly in triple-negative breast cancer (TNBC), which lacks expression of ER, PR and HER2 (4,5). Here, CARM1 is linked to triple-negative breast carcinoma.